Literature DB >> 30182366

Zinc finger protein 91 positively regulates the production of IL-1β in macrophages by activation of MAPKs and non-canonical caspase-8 inflammasome.

Chunliu Mi1, Zhe Wang1, Ming Yue Li1, Zhi Hong Zhang1, Juan Ma1, Xuejun Jin1.   

Abstract

BACKGROUND AND
PURPOSE: IL-1β is a cytokine of critical importance in inflammatory, infectious and autoimmune diseases. Zinc finger protein 91 (ZFP91) has been reported to be involved in multiple biological processes. Here, we identified a previously unknown role for ZFP91 in the production of biologically active IL-1β and investigated the underlying mechanisms of its effects. EXPERIMENTAL APPROACH: In vitro, the underlying mechanisms of ZFP91 at inhibiting the expression of IL-1β were investigated by ELISA, RT-PCR, Western blotting, immunoprecipitation and immunofluorescence assays. In vivo, colitis was induced by giving 4% dextran sulfate sodium (DSS) p.o. in drinking water for 5 days. Peritonitis was induced by injecting 700 μg alum i.p. for 12 h. KEY
RESULTS: ZFP91 activated the non-canonical caspase-8 inflammasome, which resulted in robust IL-1β secretion. Using an immunoprecipitation assay and immunofluorescence assay, we found that ZFP91 promoted the assembly of the non-canonical caspase-8 inflammasome complex. Moreover, ZFP91 enhanced the activation of ERK, p38 MAPK and JNK in macrophages. In addition, our data demonstrate that the synthesis of pro-IL-1β is dependent on activation of these MAPK signalling pathways. In vivo experiments, the symptoms and colonic inflammation associated with DSS-induced colitis were ameliorated in mice deficient in ZFP91. Furthermore, the inflammation in alum-induced peritonitis was also attenuated in mice deficient in ZFP91. CONCLUSIONS AND IMPLICATIONS: Our research describes a mechanism by which ZFP91 promotes production of IL-1β under physiological conditions and suggests that ZFP91 may be a promising therapeutic target for intervention in inflammatory, infectious and autoimmune-related diseases.
© 2018 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30182366      PMCID: PMC6240129          DOI: 10.1111/bph.14493

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

Review 1.  Proinflammatory cytokines.

Authors:  C A Dinarello
Journal:  Chest       Date:  2000-08       Impact factor: 9.410

2.  Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome.

Authors:  Christian Bauer; Peter Duewell; Christine Mayer; Hans Anton Lehr; Katherine A Fitzgerald; Marc Dauer; Jurg Tschopp; Stefan Endres; Eicke Latz; Max Schnurr
Journal:  Gut       Date:  2010-05-04       Impact factor: 23.059

3.  Internalized Cryptococcus neoformans Activates the Canonical Caspase-1 and the Noncanonical Caspase-8 Inflammasomes.

Authors:  Mingkuan Chen; Yue Xing; Ailing Lu; Wei Fang; Bing Sun; Changbin Chen; Wanqing Liao; Guangxun Meng
Journal:  J Immunol       Date:  2015-10-14       Impact factor: 5.422

4.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes.

Authors:  Stephen Ph Alexander; Doriano Fabbro; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739

5.  Isoforms of Jun kinase are differentially expressed and activated in human monocyte/macrophage (THP-1) cells.

Authors:  S C Dreskin; G W Thomas; S N Dale; L E Heasley
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

Review 6.  Inflammasome activation and IL-1β and IL-18 processing during infection.

Authors:  Frank L van de Veerdonk; Mihai G Netea; Charles A Dinarello; Leo A B Joosten
Journal:  Trends Immunol       Date:  2011-02-18       Impact factor: 16.687

7.  Identification of a novel human gene, ZFP91, involved in acute myelogenous leukemia.

Authors:  Motoko Unoki; Junichi Okutsu; Yusuke Nakamura
Journal:  Int J Oncol       Date:  2003-06       Impact factor: 5.650

8.  A Mycoplasma fermentans-derived synthetic lipopeptide induces AP-1 and NF-kappaB activity and cytokine secretion in macrophages via the activation of mitogen-activated protein kinase pathways.

Authors:  J Garcia; B Lemercier; S Roman-Roman; G Rawadi
Journal:  J Biol Chem       Date:  1998-12-18       Impact factor: 5.157

9.  FADD and caspase-8 mediate priming and activation of the canonical and noncanonical Nlrp3 inflammasomes.

Authors:  Prajwal Gurung; Paras K Anand; R K Subbarao Malireddi; Lieselotte Vande Walle; Nina Van Opdenbosch; Christopher P Dillon; Ricardo Weinlich; Douglas R Green; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  J Immunol       Date:  2014-01-22       Impact factor: 5.422

10.  HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-κB pathway in acute glaucoma.

Authors:  Wei Chi; Hongrui Chen; Fei Li; Yingting Zhu; Wei Yin; Yehong Zhuo
Journal:  J Neuroinflammation       Date:  2015-07-30       Impact factor: 8.322

View more
  8 in total

1.  Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1.

Authors:  Wenchao Wu; Geoffrey M Nelson; Raphael Koch; Katherine A Donovan; Radosław P Nowak; Tayla B Heavican-Foral; Ajit J Nirmal; Huiyun Liu; Lei Yang; Jessica Duffy; Foster Powers; Kristen E Stevenson; Marcus Kenneth Jones; Samuel Y Ng; Gongwei Wu; Salvia Jain; Ran Xu; Sam Amaka; Christopher Trevisani; Nicholas L Donaldson; Patrick R Hagner; Laurence de Leval; Philippe Gaulard; Javeed Iqbal; Anjan Thakurta; Eric S Fischer; Karen Adelman; David M Weinstock
Journal:  Blood       Date:  2022-03-31       Impact factor: 25.476

2.  Zinc finger protein 91 positively regulates the production of IL-1β in macrophages by activation of MAPKs and non-canonical caspase-8 inflammasome.

Authors:  Chunliu Mi; Zhe Wang; Ming Yue Li; Zhi Hong Zhang; Juan Ma; Xuejun Jin
Journal:  Br J Pharmacol       Date:  2018-10-15       Impact factor: 8.739

3.  Roles of miR-640 and Zinc Finger Protein 91 (ZFP91) in Angiopoietin-1-Induced In Vitro Angiogenesis.

Authors:  Sharon Harel; Veronica Sanchez-Gonzalez; Raquel Echavarria; Dominique Mayaki; Sabah Na Hussain
Journal:  Cells       Date:  2020-07-02       Impact factor: 6.600

4.  Corticotrophin-Releasing Factor Modulates the Facial Stimulation-Evoked Molecular Layer Interneuron-Purkinje Cell Synaptic Transmission in vivo in Mice.

Authors:  Wen-Yuan Wu; Yang Liu; Mao-Cheng Wu; Hong-Wei Wang; Chun-Ping Chu; Hua Jin; Yu-Zi Li; De-Lai Qiu
Journal:  Front Cell Neurosci       Date:  2020-11-26       Impact factor: 5.505

5.  ZFP91 is required for the maintenance of regulatory T cell homeostasis and function.

Authors:  Aiting Wang; Lei Ding; Zhongqiu Wu; Rui Ding; Xiao-Lu Teng; Feixiang Wang; Zhilin Hu; Lei Chen; Xiaoyan Yu; Qiang Zou
Journal:  J Exp Med       Date:  2021-02-01       Impact factor: 14.307

6.  ZFP91 promotes cell proliferation and inhibits cell apoptosis in AML via inhibiting the proteasome-dependent degradation of RIP1.

Authors:  Zhonghui Zhang; Liang Zhong; Wenran Dan; Xuan Chu; Chen Liu; Xu Luo; Peng Wan; Zhenyan Liu; Yang Lu; Xiao Wang; Beizhong Liu
Journal:  Int J Med Sci       Date:  2022-01-01       Impact factor: 3.738

7.  Facial Stimulation Induces Long-Term Potentiation of Mossy Fiber-Granule Cell Synaptic Transmission via GluN2A-Containing N-Methyl-D-Aspartate Receptor/Nitric Oxide Cascade in the Mouse Cerebellum.

Authors:  Di Lu; Peng Wan; Yang Liu; Xian-Hua Jin; Chun-Ping Chu; Yan-Hua Bing; De-Lai Qiu
Journal:  Front Cell Neurosci       Date:  2022-03-30       Impact factor: 5.505

8.  First-in-Human, Single- and Multiple-Ascending-Dose Studies in Healthy Subjects to Assess Pharmacokinetics, Pharmacodynamics, and Safety/Tolerability of Iberdomide, a Novel Cereblon E3 Ligase Modulator.

Authors:  Ying Ye; Allison Gaudy; Peter Schafer; Michael Thomas; Daniel Weiss; Nianhang Chen; Liangang Liu; Yongjun Xue; Leon Carayannopoulos; Maria Palmisano
Journal:  Clin Pharmacol Drug Dev       Date:  2020-09-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.